Effective oral cancer screening involves more than clinical guidelines -- it requires strategic patient communication. Dental professionals should establish screening as routine, describe findings objectively before assigning diagnoses, and manage referrals with clear follow-up plans to reduce patient fear and ensure proper evaluation.
- Make oral cancer screening feel routine by explaining the examination upfront to all patients, not just when suspicious findings appear.
- Describe what you observe before attempting diagnosis to gather accurate clinical information.
- The 2026 ADA guidelines recommend clinical examination as the primary screening tool, with biopsy as the preferred diagnostic method over adjunctive devices.
- Use clear, honest language when discussing findings: Explain what you see, what you cannot determine, and why referral or biopsy is needed to avoid patient misunderstanding.
- Ensure active follow-up by documenting findings, scheduling rechecks before patients leave, and verifying specialist referrals were completed.
Partway through an intraoral exam, I stopped over an area I wanted to look at again. Before I could decide what I was seeing, my patient said, “Well, that isn’t a good face.”
I had not said a word. Patients may not know oral anatomy, but they know when our expressions change. They notice the pause. By the time we call the dentist into the room, the patient may already believe something is wrong.
The oral cancer screening conversation begins before we ever say the words “oral cancer.” The 2026 oral cancer screening guidelines give us clearer direction about the clinical examination, adjunctive devices, biopsy, and referral. They do not tell us how to explain an unexpected finding to a patient who is watching our every reaction.
Make the examination routine before it feels urgent
Kelly Tanner, PhD, RDH.
I do not want the first mention of an oral cancer screening to happen after I find something. If I suddenly announce that I am beginning a screening, the patient may assume I have already seen a problem. What is routine to us can feel alarming when the patient does not know what we are doing.
I tell patients that I perform this examination on everyone. I am checking the tissues in the mouth and throat and the areas around the neck for anything that has changed or needs attention. That short explanation gives context to the examination before the patient has a reason to worry.
Saying it upfront also makes the harder conversation easier later. If I pause over an area, the patient already understands why I am looking. I am not introducing the purpose of the examination at the same time I am asking them to trust my clinical concern.
Describe what you see before you try to name it
The mouth is full of normal variations. Pigmentation, linea alba, tori, frictional changes, prominent blood vessels, and lingual tonsillar tissue may look unfamiliar to a patient even when they are familiar to us. Experience helps us recognize what is common, but familiarity can also make us move too quickly.
When I see tissue that looks different, I slow down and describe it before I try to decide what it is. Where is it? How large is it? What color is it? What does the surface look and feel like? Is it ulcerated, firm, fixed, tender, or indurated? Is there a reasonable source of trauma?
A note that says “white spot on tongue” does not give us enough information to determine whether the area is stable, healing, or changing. The photograph, measurement, texture, location, symptoms, and clinical history create the comparison we will need later. Color alone does not give us a diagnosis, and the absence of pain does not rule anything out. Early oral cancer may be painless.
What the 2026 oral cancer screening guidelines say
The 2026 ADA recommendations are part of a living guideline. Instead of waiting several years for the next complete revision, the evidence can be reviewed and the recommendations updated as new research becomes available. The protocol we learned in school may not be the one we should follow now.
The central message has not changed: Every adult should receive an updated medical, dental, and social history along with a comprehensive extraoral and intraoral examination. When tissue is suspicious or persistent, a punch or scalpel biopsy with histopathologic assessment remains the preferred and definitive method of diagnosis.
The guideline generally recommends against relying on cytology, vital staining, light-based devices, or salivary tests to determine whether a patient needs a biopsy or referral. It also recommends against using these adjuncts to screen asymptomatic adults without a clinically evident lesion.
Cytology may be considered when biopsy is not possible, advisable, or indicated. A negative result does not end the evaluation if the tissue persists or progresses. Vital staining and light-based devices should not determine whether a visible abnormality needs biopsy or referral, and salivary adjuncts remain limited to research settings.
The clinical examination still leads, and we still own the decision about what happens next.
How to discuss an oral tissue change without creating fear
Sometimes our reassurance makes it worse. We say “lesion,” and the patient hears “cancer.” Then we say, “It is probably nothing,” while handing them a referral to an oral surgeon. Now the patient has to decide whether to believe what we said or what we just handed them.
I tell the patient what I can see and what I cannot determine. I may say, “I see an area that looks different from the tissue around it. Several things can cause a change like this, so I want the dentist to look at it with me.” That is truthful without assigning a diagnosis.
If a referral is appropriate, I explain that the specialist may recommend a biopsy because we need more information. I might say, “A biopsy is how we get an answer. It does not mean we have decided you have cancer.”
When to recheck or refer an oral tissue change
A 10- to 14-day recheck has a place when there is a likely source of trauma and the tissue does not already appear suspicious. But watching an area should be active. Address the source of trauma, photograph and measure the finding, and schedule the recheck before the patient leaves.
An unexplained indurated area on the lateral border of the tongue is different from an ulcer next to a fractured tooth. The clinical presentation should determine whether we recheck or refer. The 10- to 14-day window should never become permission to delay a finding that needs prompt evaluation.
If the area has not resolved within 10 to 14 days and there is no definitive diagnosis or treatment plan, the guideline calls for prompt biopsy or specialist referral. I want the patient to know when we will look again, what changes should prompt an earlier call, and what will happen if the tissue remains. Telling someone to “keep an eye on it” is not a plan.
A referral form does not complete the referral
Fear, cost, transportation, and the absence of pain can all keep a patient from scheduling with a specialist. Someone in the practice must own the follow-through. Did the patient schedule? Was the evaluation completed? Did we receive the report?
The patient should understand why we are referring, how soon they should be seen, and what they can expect next. The record should include the clinical description, photographs when available, the dentist’s assessment, the referral time frame, and the follow-up status. If the patient declines, document what was explained, the risk of delaying, and the continued follow-up plan.
That follow-through is part of the screening too. It is how we make sure the patient does not disappear between our operatory and the specialist’s office.
The conversation is part of the screening
I do not expect us to diagnose every tissue change from the chair. I do expect us to notice when something does not match, describe it well, involve the dentist, and help the patient understand the next step. The hard part is often deciding what to say while we are still deciding what the tissue may represent. Patients deserve honesty, but they also deserve a conversation that does not make them believe we know more than we do.
In my upcoming course, “Oral Cancer Screening Conversations: How to Look Without Scaring People,” we move from the guideline to the patient in the chair. We work through the findings that change the urgency, the questions patients ask when they are frightened, and the language that helps us explain a recheck, referral, or biopsy without minimizing the concern or creating unnecessary fear.
You can know the guideline cold and still freeze when the patient asks, “Is it cancer?” If you want to be notified when the course becomes available, subscribe to my Substack.
I also write there about the clinical decisions and patient conversations that do not always fit neatly into an article or continuing education program.
Kelly Tanner, PhD, RDH, is a contributing author to DrBicuspid, where she shares insights and strategies to empower dental hygienists in their careers. As a leader in clinical training, professional development, and team dynamics, Tanner provides resources to help hygienists elevate their practice and personal growth. For further support, join her free Facebook group, Next Level Dental Hygiene Career and Personal Development, and explore group training and on-demand courses at www.nextleveldentalhygiene.com.
The comments and observations expressed herein do not necessarily reflect the opinions of DrBicuspid.com, nor should they be construed as an endorsement or admonishment of any particular idea, vendor, or organization.
